Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells

International Journal of Cancer

Volumn 97, Issue 2, 2002, Pages 168-172

  Tan, Guolin ^a,b   Heqing, Li ^a   Jiangbo, Chen ^a   Ming, Jiang ^a   Yanhong, Ma ^a   Xianghe, Liu ^a   Hong, Sun ^a   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Caspase; Nasopharyngeal cancer; p53; Paclitaxel

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTATE FLUOROMETHYLKETONE; CASPASE 3; CASPASE INHIBITOR; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROPIDIUM IODIDE; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DEATH; CELL GROWTH; CELL LINE; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, BCL-2; HUMANS; NASOPHARYNGEAL NEOPLASMS; PACLITAXEL; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0037049992     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1591     Document Type: Article

References (33)

1. Nasopharyngeal carcinoma
2. Treatment of stage I nasopharyngeal carcinoma: Analysis of the patterns of relapse and the results of withholding elective neck irradiation
3. Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas
4. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma
5. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents
6. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck
7. Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma
8. Taxol photolabels the Nterminal 31 amino acids of β-tubulin
9. Mechanism of mitototic block and inhibition of cell proliferation by taxol at low concentrations
10. Mitotic block induced in Hela cells by low concentrations of paclitaxel results in abnormal mitotic exit and apoptotic cell death
11. The use and action of drugs in analyzing mitosis
12. The spindle assembly checkpoint
13. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinasedependent and -independent pathways in ovarian cancer cells
14. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: A review
15. Activation of MAD 2 checkprotein and persistence of cyclin B1/CDC 2 activity associate with paclitaxelinduced apoptosis in human nasopharyngeal carcinoma cells
16. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
17. Establishment and characterization of two epithelial tumor cell lines latently infected with EpsteinBarr virus and derived from nasopharyngeal carcinomas
18. Absence of p53 gene mutations in primary nasopharyngeal carcinomas
19. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines
20. Paclitaxel induces programmed cell death in MDAMB-468 human breast cancer cells
21. Induction of apoptosis and supression of clonogenicity of ovarian carcinoma cells with estrogen mustard
22. Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together
23. Taxel induces bcl-2 phosphorylation and death of prostate cancer cells
24. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
25. p53 activates the CD95(APO-1/FAS) gene in response to DNA damage by anticancer drugs
26. Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction
27. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase
28. P53 mutations do not predict response to paclitaxel/radiation for non-small cell lung carcinoma
29. p53 gene status and response to Platinum/Paclitaxel-based chemotherapy in advanced ovarian carcinoma
30. p53-independent apoptosis induced by paclitaxel through an indirect mechanism
31. A crucial role of caspase 3 and caspase 8 in paclitaxel-induced apoptosis
32. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak